Methimazole

Methimazole is a thionamide antithyroid agent that inhibits the synthesis of thyroid hormones. It was first introduced as an antithyroid agent in 1949 and is now commonly used in the management of hyperthyroidism, particularly in those for whom more aggressive options including surgery or radioactive iodine therapy are inappropriate. It is grouped under the following drug class(es): Thyroid agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Tapazole, Mercazolyl, Thymidazole, Basolan, Danantizol and Frentirox. Its PubChem CID is 1349907.